The VCU Neurology welcomes new chairman - A. Gordon Smith, MD, FAAN
19 March 2018
Dr. Smith has most recently served as professor of neurology and vice chair for research at the University of Utah, where he also is chief of the division of neuromuscular medicine and director of the Jack H. Petajan EMG Laboratory.
Dr. Smith’s research team focuses on peripheral neuropathy in diabetes and obesity. He has a particular interest in biomarker development and novel clinical trial design in peripheral neuropathy, a condition resulting from damage to the peripheral nervous system and causing weakness, numbness and pain.
He has led and participated in numerous clinical trials in neuromuscular disorders as well as in NeuroNEXT, the Network for Excellence in Neuroscience Clinical Trials that is funded by the National Institute of Neurological Disorders and Stroke. Serving on the network’s executive committee, Dr. Smith is principal investigator of the TopCSPN trial, the first large scale randomized trial of a treatment to alter the natural history of cryptogenic sensory peripheral neuropathy, one of the most common neurological disorders.
Dr. Smith serves on the board of directors of the American Academy of Neurology and is chair of its education committee. He is active in the Peripheral Nerve Society, where he is a former member of the board of directors, and currently serves as the secretary on the American Brain Foundation’s board of trustees.
A native of Richmond, Dr. Smith earned his bachelor’s degree from the University of Virginia and his medical degree from the Mayo Medical School. He completed his neurology residency and a neuromuscular fellowship at the University of Michigan.
Last Modified: 22 March 2018, 11:03 AM, by: Jennifer Cheatham Rew